Shimadzu Corp. (7701) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

541.7 k

Shareholding (Mar 2025)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROE of 11.59%

Company has very low debt and has enough cash to service the debt requirements

Flat results in Jun 25

With ROE of 11.01%, it has a expensive valuation with a 2.04 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 1,075,623 Million (Large Cap)

P/E

18.00

Industry P/E

Dividend Yield

0.01%

Debt Equity

-0.27

Return on Equity

10.69%

Price to Book

2.18

Revenue and Profits:

Net Sales:

118,370 Million

(Quarterly Results - Jun 2025)

Net Profit:

7,921 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

21.79%

6 Months

23.9%

1 Year

-0.95%

2 Years

13.92%

3 Years

8.44%

4 Years

-10.27%

5 Years

16.38%

Shimadzu Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Shimadzu Corp. Hits Day Low at JPY 4,008 Amid Price Pressure

Shimadzu Corp. faced a decline on November 6, 2025, contrasting with the broader market's performance. The company has seen a year-to-date drop, despite maintaining strong management efficiency and low debt levels. Its stock valuation remains elevated compared to historical averages, prompting close observation from stakeholders.

Shimadzu Corp. Hits Day Low of JPY 4,109 Amid Price Pressure

Shimadzu Corp., a key player in the Pharmaceuticals & Biotechnology sector, saw its stock decline significantly on October 29, 2025. Despite a challenging trading session, the company maintains strong management efficiency with a return on equity of 10.69% and a low debt profile, although its stock valuation remains elevated.

Shimadzu Corp. Hits Day High with Strong 4.68% Intraday Surge

Shimadzu Corp., a key player in the Pharmaceuticals & Biotechnology sector, saw its stock rise significantly on October 22, 2025. Despite recent gains, the company has struggled over the past year, with a notable decline, contrasting with the broader market's performance. Its market capitalization stands at JPY 1,075,623 million.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.94%

EBIT Growth (5y)

11.38%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

1.08

Tax Ratio

25.03%

Dividend Payout Ratio

35.96%

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

23.39%

ROE (avg)

11.59%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.04

EV to EBIT

12.21

EV to EBITDA

9.61

EV to Capital Employed

2.44

EV to Sales

1.62

PEG Ratio

Dividend Yield

0.01%

ROCE (Latest)

19.95%

ROE (Latest)

11.01%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 1.22% vs 7.09% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -20.69% vs -10.03% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "118,370.00",
          "val2": "116,938.00",
          "chgp": "1.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17,412.00",
          "val2": "15,952.00",
          "chgp": "9.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "65.00",
          "val2": "73.00",
          "chgp": "-10.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "26.00",
          "val2": "68.00",
          "chgp": "-61.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7,921.00",
          "val2": "9,987.00",
          "chgp": "-20.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "102.90%",
          "val2": "93.70%",
          "chgp": "0.92%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 5.30% vs 6.15% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -5.72% vs 9.59% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "539,047.00",
          "val2": "511,895.00",
          "chgp": "5.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "92,402.00",
          "val2": "91,861.00",
          "chgp": "0.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "278.00",
          "val2": "294.00",
          "chgp": "-5.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,312.00",
          "val2": "145.00",
          "chgp": "-1,004.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "53,774.00",
          "val2": "57,037.00",
          "chgp": "-5.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "133.10%",
          "val2": "142.10%",
          "chgp": "-0.90%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

118,370.00

116,938.00

1.22%

Operating Profit (PBDIT) excl Other Income

17,412.00

15,952.00

9.15%

Interest

65.00

73.00

-10.96%

Exceptional Items

26.00

68.00

-61.76%

Consolidate Net Profit

7,921.00

9,987.00

-20.69%

Operating Profit Margin (Excl OI)

102.90%

93.70%

0.92%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 1.22% vs 7.09% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -20.69% vs -10.03% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

539,047.00

511,895.00

5.30%

Operating Profit (PBDIT) excl Other Income

92,402.00

91,861.00

0.59%

Interest

278.00

294.00

-5.44%

Exceptional Items

-1,312.00

145.00

-1,004.83%

Consolidate Net Profit

53,774.00

57,037.00

-5.72%

Operating Profit Margin (Excl OI)

133.10%

142.10%

-0.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 5.30% vs 6.15% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -5.72% vs 9.59% in Mar 2024

All Annual Results

Company CV

About Shimadzu Corp.

Shimadzu Corp.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Shimadzu Corp.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

High Management Efficiency with a high ROE of 11.59%

Company has very low debt and has enough cash to service the debt requirements

Flat results in Jun 25

With ROE of 11.01%, it has a expensive valuation with a 2.04 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Shimadzu Corp. Hits Day Low at JPY 4,008 Amid Price Pressure

Shimadzu Corp. Hits Day Low of JPY 4,109 Amid Price Pressure

Shimadzu Corp. Hits Day High with Strong 4.68% Intraday Surge

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Mar'25

About Shimadzu Corp.

Company Coordinates